Skip to main content
OpenTrials
Completed

NCT Number: NCT02072798

Antibiotics and Gut Microbiota Among Newborn Infants

Background Women undergoing Caesarean Section (CS) have an increased risk of postpartum infections compared to women undergoing vaginal delivery. In Denmark the incidence of post-CS infections is 7-10%. The most common infections are endometritis, Urinary tract infections (UTI) and wound infections (WI).

Prophylactic antibiotics are effective in preventing postoperative infections and national guidelines recommend that antibiotics should be administered as a single dose immediately before surgical incision. CS is an exception to this pre-incision administration approach. National guidelines recommend administration of antibiotics after umbilical cord clamping to avoid exposure of the child to antibiotics before birth. Recent studies of antibiotic prophylaxis for CS suggest that prophylactic antibiotics administered before incision compared to after umbilical cord clamping may reduce post-CS infections by up to 50%. Two Cochrane reviews from 2012 criticize these types of studies for lack of data for outcomes on the baby and on late infection in the mother.

At birth, all mammals must rapidly adapt to intake of complex milk nutrients via the gut and simultaneously tolerate the invasion of billions of microbes. This requires rapid maturation of the digestive and immune functions to avoid gut disorders and infections. Full-term, breast-fed infants normally adapt well, but factors such as caesarean birth, high hygiene levels, antibiotics treatment and formula feeding may inhibit immune development both short and long term. Birth by caesarean section in high-hygiene hospital environments, and widespread use of antibiotics, are factors that reduce gut microbiota density and diversity in the newborn for some time after birth. On the other hand, high-hygiene environments and antibiotics are essential tools to combat infections, especially for the weakest newborn infants.

This pilot study will be a feasibility study to the original study, which examines the effect of change in timing of prophylactic antibiotics on the rate of post-CS infections (endometritis, UTI and WI). The pilot study focus on antibiotic and changes in the gut microbiota of newborn infants. The feasibility study will only include pregnant women in Odense with a body mass index below 30, and planned cesarean section.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Odense University Hospital

Odense, Fyn, 5000, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 year
  • Women, who can read and understand Danish
  • A gestational age ≥ completed 28 weeks of gestation
  • Rupture of membranes and active labour (uterine contractions) is allowed.
  • BMI < 30

Exclusion criteria

  • Hypersensitivity to cefuroxime or to any other cephalosporin antibiotics
  • Previous immediate and/or severe hypersensitivity reaction to penicillin or any other beta-lactam antibiotic.
  • Systemic exposure to any antibiotic agent within 1 week before delivery Antibiotic indicated due to PROM, fever, group B Streptococcus or other indications at the time of caesarean section.
  • Women being immunologically incompetent (e.g. HIV positive)
  • Very sick newborn infants transferred to a neonatal intensive care unit and treated with antibiotics will be excluded from the study

Treatment and study plan

cefuroxime

Drug

iv Cefuroxime 1,5g administered 15-60 minutes before incision versus iv Cefuroxime 1,5g administered after umbilical cord clamping

Other names: Cefuroxime "Fresenius Kabi"

Primary outcomes

  1. Maternal: incidence of post-CS infection (endometritis, urinary tract infections and wound infection) in each study group

    Time frame: Within the first 30 days after surgery

  2. Infant: fecal microbiota at the tenth day of life

    Time frame: on the tenth day of life

Secondary outcomes

  1. Maternal: Length of hospitalization

    Time frame: Within the first 30 days after Caesarean Section

  2. Maternal: readmissions to hospital on suspicion of postpartum infection following cesarean section

    Time frame: Within the first 30 days after Caesarean Section

  3. Antibiotic treatment

    Time frame: within the first 30 days after Caesarean Section

  4. Infant: concentration of cefuroxime in blood samples

    Time frame: during the first 24 hours of life

  5. Infant: immunological analyses in blood samples on day 3

    Time frame: On the third day of life

Sponsors and collaborators

Lead sponsor

Odense University Hospital

Other

Collaborators

  • Aase and Ejnar Danielsens Foundation
  • Region of Southern Denmark
  • University of Copenhagen
  • University of Southern Denmark

Registry information

Official study title

Antibiotic Prophylaxis for Postpartum Infections Following Caesarean Section

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 27, 2014
Registry last updated
Aug 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.